Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
2(13%)
Results Posted
0%(0 trials)
Terminated
2(13%)

Phase Distribution

Ph not_applicable
1
6%
Ph phase_2
2
13%
Ph phase_3
4
25%
Ph phase_4
5
31%

Phase Distribution

0

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(2)
Completed(7)
Terminated(3)
Other(4)

Detailed Status

Completed7
unknown4
Terminated2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 34 (33.3%)
Phase 45 (41.7%)
N/A1 (8.3%)

Trials by Status

terminated213%
withdrawn16%
unknown425%
recruiting213%
completed744%

Recent Activity

2 active trials
Showing 5 of 16
recruitingphase_4

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

NCT06284642
completedphase_4

Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: a Randomized Controlled Trial

NCT06802679
recruiting

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

NCT06194968
completed

Brain Aneurysms: Utility of Cisternal Urokinase Irrigation

NCT04792944
unknownphase_4

Local Thrombolytics Before Thrombectomy in STEMI

NCT01568931
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06284642Phase 4

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Recruiting
NCT06802679Phase 4

Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: a Randomized Controlled Trial

Completed
NCT06194968

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Recruiting
NCT04792944

Brain Aneurysms: Utility of Cisternal Urokinase Irrigation

Completed
NCT01568931Phase 4

Local Thrombolytics Before Thrombectomy in STEMI

Unknown
NCT02854592

Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset

Completed
NCT03997292

Intravenous Thrombolysis Registry for Acute Ischemic Stroke in China

Withdrawn
NCT02414802Not Applicable

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

Unknown
NCT00823225Phase 3

Urokinase Therapy in Patients With Diabetic Foot Syndrome

Terminated
NCT01638585Phase 3

Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia

Terminated
NCT00798278Phase 3

Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood

Completed
NCT01134237Phase 3

Intrapleural Urokinase for Retained Hemothorax

Unknown
NCT00537498Phase 2

Urokinase Therapy in Diabetic Foot Syndrome

Completed
NCT00968929Phase 4

Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)

Completed
NCT00799968Phase 4

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

Completed
NCT00502632Phase 2

Dornase Alfa and Urokinase for Kids With Pleural Empyema

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16